CLINICAL_TRIALS
trial_result
· 2018-12-06
Clinical Trial Update: A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A [Phase 2, Phase 3]
Summary
A completed Phase 2/3 trial evaluating BAY94-9027 for safety and efficacy in severe Hemophilia A has posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Hemophilia A | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-12-06